Cargando…

The Soluble Form of CTLA-4 from Serum of Patients with Autoimmune Diseases Regulates T-Cell Responses

Cytotoxic T lymphocyte associated antigen-4 (CTLA-4) is a costimulatory receptor transducing a potent inhibitory signal. Increasing evidence showed that CTLA-4 gene is an important susceptibility locus for autoimmune disorders. Alternatively spliced mRNA generates a soluble form, called sCTLA-4. Whe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simone, Rita, Pesce, Giampaola, Antola, Princey, Rumbullaku, Margarita, Bagnasco, Marcello, Bizzaro, Nicola, Saverino, Daniele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925529/ https://www.ncbi.nlm.nih.gov/pubmed/24605322 http://dx.doi.org/10.1155/2014/215763

Ejemplares similares

Serum LAIR-2 Is Increased in Autoimmune Thyroid Diseases
por: Simone, Rita, et al.
Publicado: (2013)

The soluble CTLA-4 receptor and its role in autoimmune diseases: an update
por: Saverino, Daniele, et al.
Publicado: (2010)

High Levels of Soluble Ctla-4 Are Present in Anti-Mitochondrial Antibody Positive, but Not in Antibody Negative Patients with Primary Biliary Cirrhosis
por: Saverino, Daniele, et al.
Publicado: (2014)

A Soluble Form of CTLA-4 Is Present in Paediatric Patients with Acute Lymphoblastic Leukaemia and Correlates with CD1d(+) Expression
por: Simone, Rita, et al.
Publicado: (2012)

92 Serum CTLA-4 AND IL-10 in Hymenoptera Venom Immunotherapy: Equivalence of Different Induction Regimens
por: Riccio, Anna Maria, et al.
Publicado: (2012)

Effects of Different Up-Dosing Regimens for Hymenoptera Venom Immunotherapy on Serum CTLA-4 and IL-10
por: Riccio, Anna Maria, et al.
Publicado: (2012)

Accuracy of receptor-based methods for detection of thyrotropin-receptor autoantibodies: a new automated third-generation immunoassay shows higher analytical and clinical sensitivity for the differential diagnosis of hyperthyroidism
por: Tozzoli, Renato, et al.
Publicado: (2010)

Iodoprophylaxis and thyroid autoimmunity: an update
por: Teti, Claudia, et al.
Publicado: (2021)

Standardization and Quality Assessment Under the Perspective of Automated Computer-Assisted HEp-2 Immunofluorescence Assay Systems
por: Cinquanta, Luigi, et al.
Publicado: (2021)

The ANA-reflex test as a model for improving clinical appropriateness in autoimmune diagnostics
por: Tonutti, Elio, et al.
Publicado: (2016)

Investigation of Soluble and Transmembrane CTLA-4 Isoforms in Serum and Microvesicles
por: Esposito, Laura, et al.
Publicado: (2014)

Gene and protein expression of a soluble form of CTLA-4 in a healthy dog
por: TAGAWA, Michihito, et al.
Publicado: (2017)

Autoantibody Profiles in Autoimmune Rheumatic Diseases
por: Bizzaro, Nicola
Publicado: (2019)

CTLA-4: a negative regulator of autoimmune disease
Publicado: (1996)

Autoimmunity Highlights: a bridge between the clinic and the laboratory
por: Bizzaro, Nicola
Publicado: (2010)

Stimulation of Human CD4(+) T Lymphocytes via TLR3, TLR5 and TLR7/8 Up-Regulates Expression of Costimulatory and Modulates Proliferation
por: Simone, Rita, et al.
Publicado: (2009)

Autoimmunity and Gastric Cancer
por: Bizzaro, Nicola, et al.
Publicado: (2018)

Anti-rods/rings autoantibody seropositivity does not affect response to telaprevir treatment for chronic hepatitis C infection
por: Calise, S. John, et al.
Publicado: (2016)

CTLA-4 and Autoimmunity: New Twists in the Tale
por: Walker, Lucy S.K.
Publicado: (2015)

A case of autoimmune enteropathy with CTLA4 haploinsufficiency
por: Miyazaki, Haruka, et al.
Publicado: (2022)

Soluble form of CTLA‐4 is a good predictor for tumor recurrence after radiofrequency ablation in hepatocellular carcinoma patients
por: Teng, Wei, et al.
Publicado: (2022)

Anti-DFS70 antibodies detected by specific methods in patients with thrombosis or recurrent pregnancy loss: no evidence of an association
por: Bizzaro, Nicola, et al.
Publicado: (2020)

CTLA-4 as a genetic determinant in autoimmune Addison’s disease
por: Wolff, A S B, et al.
Publicado: (2015)

Current understanding of CTLA-4: from mechanism to autoimmune diseases
por: Hossen, Md Munnaf, et al.
Publicado: (2023)

Automation, consolidation, and integration in autoimmune diagnostics
por: Tozzoli, Renato, et al.
Publicado: (2015)

CTLA4-Linked Autoimmunity in the Pathogenesis of Endometriosis and Related Infertility: A Systematic Review
por: Mikuš, Mislav, et al.
Publicado: (2022)

TGFβ2 Induces the Soluble Isoform of CTLA-4 – Implications for CTLA-4 Based Checkpoint Inhibitor Antibodies in Malignant Melanoma
por: Khanolkar, Rahul C., et al.
Publicado: (2022)

Cytotoxic T Lymphocyte–associated Antigen 4 (CTLA-4) Regulates the Unfolding of Autoimmune Diabetes
por: Lühder, Fred, et al.
Publicado: (1998)

CTLA4-Ig treatment prevents murine experimental autoimmune encephalomyelitis
por: Cross, A.H., et al.
Publicado: (1994)

Increased production of soluble CTLA-4 in patients with spondylarthropathies correlates with disease activity
por: Toussirot, Éric, et al.
Publicado: (2009)

The Role of CTLA-4 Exon-1 49 A/G Polymorphism and Soluble CTLA-4 Protein Level in Egyptian Patients with Behçet's Disease
por: Abdel Galil, Sahar M., et al.
Publicado: (2014)

Sex and interleukin-6 are prognostic factors for autoimmune toxicity following treatment with anti-CTLA4 blockade
por: Valpione, Sara, et al.
Publicado: (2018)

Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunity
por: Paterson, Alison M., et al.
Publicado: (2015)

Autoimmune manifestations of CTLA-4 haploinsufficiency in two patients of Southeast Asian ethnicity
por: Lim, Xin Rong, et al.
Publicado: (2023)

Immunoregulatory soluble CTLA-4 modifies effector T-cell responses in systemic lupus erythematosus
por: Dahal, Lekh N., et al.
Publicado: (2016)

Antibody-mediated neutralization of soluble MIC significantly enhances CTLA4 blockade therapy
por: Zhang, Jingyu, et al.
Publicado: (2017)

RGMB enhances the suppressive activity of the monomeric secreted form of CTLA-4
por: Sekiya, Takashi, et al.
Publicado: (2019)

Elevated IL-19 Serum Levels in Patients With Pernicious Anemia and Autoimmune Gastritis
por: Della Bella, Chiara, et al.
Publicado: (2022)

Clinical Relevance of the serum CTLA-4 in Cats with Mammary Carcinoma
por: Urbano, Ana Catarina, et al.
Publicado: (2020)

Mice transgenic for a soluble form of murine CTLA-4 show enhanced expansion of antigen-specific CD4+ T cells and defective antibody production in vivo
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_4escgb0eael6g87iaf6dbrjuk8